Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2023 Sep 18:2023.09.18.23295739. [Version 1] doi: 10.1101/2023.09.18.23295739

Polygenic Risk of Epilepsy and Post-Stroke Epilepsy

Cyprien A Rivier, Santiago Clocchiatti-Tuozzo, Shubham Misra, Johan Zelano, Rajarshi Mazumder, Lauren H Sansing, Adam de Havenon, Lawrence J Hirsch, David S Liebeskind, Emily J Gilmore, Kevin N Sheth, Jennifer A Kim, Bradford B Worrall, Guido Falcone, Nishant K Mishra
PMCID: PMC10543238  PMID: 37790357

ABSTRACT

Background and Aims

Epilepsy is highly heritable, with numerous known genetic risk loci. However, the genetic predisposition’s role in post-acute brain injury epilepsy remains understudied. This study assesses whether a higher genetic predisposition to epilepsy raises post-stroke or Transient Ischemic Attack (TIA) survivor’s risk of Post-Stroke Epilepsy (PSE).

Methods

We conducted a three-stage genetic analysis. First, we identified independent epilepsy-associated ( p <5x10 −8 ) genetic variants from public data. Second, we estimated PSE-specific variant weights in stroke/TIA survivors from the UK Biobank. Third, we tested for an association between a polygenic risk score (PRS) and PSE risk in stroke/TIA survivors from the All of Us Research Program. Primary analysis included all ancestries, while a secondary analysis was restricted to European ancestry only. A sensitivity analysis excluded TIA survivors. Association testing was conducted via multivariable logistic regression, adjusting for age, sex, and genetic ancestry.

Results

Among 19,708 UK Biobank participants with stroke/TIA, 805 (4.1%) developed PSE. Likewise, among 12,251 All of Us participants with stroke/TIA, 394 (3.2%) developed PSE. After establishing PSE-specific weights for 39 epilepsy-linked genetic variants in the UK Biobank, the resultant PRS was associated with elevated odds of PSE development in All of Us (OR:1.16[1.02-1.32]). A similar result was obtained when restricting to participants of European ancestry (OR:1.23[1.02-1.49]) and when excluding participants with a TIA history (OR:1.18[1.02-1.38]).

Conclusions

Our findings suggest that akin to other forms of epilepsy, genetic predisposition plays an essential role in PSE. Because the PSE data were sparse, our results should be interpreted cautiously.

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES